INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.
NCT00276003
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
22
Enrollment
OTHER
Sponsor class
Conditions
Non-Hodgkin's Lymphoma
Cancer
Interventions
DRUG:
Gemcitabine, Irinotecan, Allopurinol.
Sponsor
University of New Mexico